These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 17438586)

  • 1. Flow cytometry with anti HLA-antibodies: a simple but highly sensitive method for monitoring chimerism and minimal residual disease after HLA-mismatched stem cell transplantation.
    Schumm M; Feuchtinger T; Pfeiffer M; Hoelle W; Bethge W; Ebinger M; Kuci S; Handgretinger R; Lang P
    Bone Marrow Transplant; 2007 Jun; 39(12):767-73. PubMed ID: 17438586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recipient-derived cells after cord blood transplantation: dynamics elucidated by multicolor FACS, reflecting graft failure and relapse.
    Watanabe N; Takahashi S; Ishige M; Ishii Y; Ooi J; Tomonari A; Tsukada N; Konuma T; Kato S; Sato A; Tojo A; Nakauchi H
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):693-701. PubMed ID: 18489995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescent in situ hybridization on flow-sorted cells as a tool for evaluating minimal residual disease or chimerism after allogenic bone marrow transplantation.
    Cotteret S; Belloc F; Boiron JM; Bilhou-Nabera C; Dumain P; Boyer C; Lacombe F; Reiffers J; Bernard P
    Cytometry; 1998 Oct; 34(5):216-22. PubMed ID: 9822307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of plasma-cell chimerism after allogeneic stem cell transplantation by highly sensitive real-time PCR based on sequence polymorphism and its value to quantify minimal residual disease in patients with multiple myeloma.
    Kröger N; Zagrivnaja M; Schwartz S; Badbaran A; Zabelina T; Lioznov M; Ayuk F; Zander A; Fehse B
    Exp Hematol; 2006 May; 34(5):688-94. PubMed ID: 16647575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishing a Population-Based HLA-Antibody Panel for Flow Cytometric Monitoring of Chimerism in HLA-Haploidentical Stem Cell Transplantation.
    Choe W; Hwang MA; Jang S; Park CJ; Chi HS; Im HJ
    Ann Clin Lab Sci; 2016; 46(2):161-7. PubMed ID: 27098622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of human monoclonal HLA Class I antibodies to evaluate the kinetics of donor chimerism in different cell subsets after double-cord-blood transplantation in the NOD/SCID model.
    van Hensbergen Y; Mulder A; Cornelissen JJ; Brand A
    Transfusion; 2013 Jan; 53(1):104-14. PubMed ID: 22554346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. X chromosome methylation-based chimerism assay for sex-mismatched hematopoietic stem cell transplantation.
    Yamane A; Karasawa M; Maehara T; Tsukamoto N; Nojima Y
    Bone Marrow Transplant; 2001 Nov; 28(10):969-73. PubMed ID: 11753553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive B-cell only flow cytometric crossmatch: implications for renal transplantation.
    Delgado JC; Eckels DD
    Exp Mol Pathol; 2008 Aug; 85(1):59-63. PubMed ID: 18499103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follow-up of chimerism status after allogeneic HLA-mismatched stem cell transplantation by detection of non-shared HLA alleles.
    Gallardo D; Rodríguez-Luaces M; Aróstegui JI; Ferrá C; Berlanga JJ; Querol S; García-López J; Grañena A
    Haematologica; 2000 Aug; 85(8):848-54. PubMed ID: 10942932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishing the method of chimerism monitoring after allogeneic stem cell transplantation using multiplex polymerase chain reaction amplification of short tandem repeat markers and Amelogenin.
    Sufliarska S; Minarik G; Horakova J; Bodova I; Bojtarova E; Czako B; Mistrik M; Drgona L; Demitrovicova M; Lakota J; Krivosikova M; Kovacs L
    Neoplasma; 2007; 54(5):424-30. PubMed ID: 17688372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of killer immunoglobulin-like receptor/HLA ligand matching on achievement of T-cell complete donor chimerism in related donor nonmyeloablative allogeneic hematopoietic stem cell transplantation.
    Sobecks RM; Ball EJ; Askar M; Theil KS; Rybicki LA; Thomas D; Brown S; Kalaycio M; Andresen S; Pohlman B; Dean R; Sweetenham J; Macklis R; Bernhard L; Cherni K; Copelan E; Maciejewski JP; Bolwell BJ
    Bone Marrow Transplant; 2008 Apr; 41(8):709-14. PubMed ID: 18195688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
    Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
    Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of fluorescent in situ hybridization and multiplex short tandem repeat polymerase chain reaction for quantifying chimerism after stem cell transplantation.
    Buño I; Nava P; Simón A; González-Rivera M; Jiménez JL; Balsalobre P; Serrano D; Carrión R; Gómez-Pineda A; Díez-Martín JL
    Haematologica; 2005 Oct; 90(10):1373-9. PubMed ID: 16219574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly sensitive patient-specific real-time PCR SNP assay for chimerism monitoring after allogeneic stem cell transplantation.
    Eshel R; Vainas O; Shpringer M; Naparstek E
    Lab Hematol; 2006; 12(1):39-46. PubMed ID: 16513545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to crossreactive HLA antigens. Evaluation by cytotoxicity, flow cytometry, and inhibition of monoclonal antibody binding.
    Scornik JC; LeFor WM
    Transplantation; 1987 Feb; 43(2):235-40. PubMed ID: 3544381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRD detection of leukemia relapse using HLA typing by FACS in combination with FISH after mismatched allogeneic stem cell transplantation.
    Miyachi M; Watanabe E; Watanabe N; Tsuma Y; Kawashima-Goto S; Tamura S; Imamura T; Ishida H; Hosoi H
    Pediatr Transplant; 2014 Aug; 18(5):E180-4. PubMed ID: 24813938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A SYBR green-based real-time PCR method for detection of haemopoietic chimerism in allogeneic haemopoietic stem cell transplant recipients.
    Bai L; Deng YM; Dodds AJ; Milliken S; Moore J; Ma DD
    Eur J Haematol; 2006 Nov; 77(5):425-31. PubMed ID: 16899058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical cytometry and progress in HLA antibody detection.
    Bray RA; Tarsitani C; Gebel HM; Lee JH
    Methods Cell Biol; 2011; 103():285-310. PubMed ID: 21722808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The virtual crossmatch--a screening tool for sensitized pediatric heart transplant recipients.
    Zangwill SD; Ellis TM; Zlotocha J; Jaquiss RD; Tweddell JS; Mussatto KA; Berger S
    Pediatr Transplant; 2006 Feb; 10(1):38-41. PubMed ID: 16499585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.